What is NDC 51662-1430?

51662-1430 is the product NDC for Tigan(R) (Trimethobenzamide Hydrochloride), Trimethobenzamide hydrochloride 100 mg/mL injection, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Tigan(R) (Trimethobenzamide Hydrochloride).

What is the active ingredient?

Trimethobenzamide hydrochloride.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tigan(R) (Trimethobenzamide Hydrochloride)?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 51662-1430

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1430Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1430Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1430-1	5166214300151662143001	2 mL in 1 VIAL, SINGLE-DOSE (51662-1430-1)Marketed from Jan 10, 2020
51662-1430-3	5166214300351662143003	25 POUCH in 1 CASE (51662-1430-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1430-2) / 2 mL in 1 VIAL, SINGLE-DOSEMarketed from Dec 11, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tigan(R) (Trimethobenzamide Hydrochloride)
Generic name (nonproprietary): tigan(r) (trimethobenzamide hydrochloride)
Active ingredients: Trimethobenzamide hydrochloride — 100 mg/mL
Dosage form: Injection
Route: Intramuscular
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 017530
Marketing start: Jan 10, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Emesis Suppression (Physiologic effect)
Identifiers: Product ID 51662-1430_0ffba8c5-bf5e-a665-e063-6294a90a64f6SPL ID 0ffba8c5-bf5e-a665-e063-6294a90a64f6SPL set ID 9bd0bfa0-c189-751c-e053-2a95a90a5f5aRxCUI 1726680UNII WDQ5P1SX7Q
Pharmacologic class: Antiemetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662143001 followed by a unit qualifier and the quantity

Package 51662-1430-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2024.

Indications (excerpt from the label)

INDICATIONS Tigan® is indicated for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1430

What is NDC 51662-1430?: 51662-1430 is the product NDC for Tigan(R) (Trimethobenzamide Hydrochloride), Trimethobenzamide hydrochloride 100 mg/mL injection, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tigan(R) (Trimethobenzamide Hydrochloride).
What is the active ingredient?: Trimethobenzamide hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tigan(R) (Trimethobenzamide Hydrochloride)?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 017530

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 017530
Product	Strength	Form · route	Labeler	Product NDC
Tigantrimethobenzamide hydrochloride	Trimethobenzamide hydrochloride 100 mg/mL	InjectionIntramuscular	Henry Schein, Inc	0404-9964
Tigantrimethobenzamide hydrochloride	Trimethobenzamide hydrochloride 100 mg/mL	InjectionIntramuscular	Par Health USA, LLC	42023-119

Tigan(R) (Trimethobenzamide Hydrochloride) NDC 51662-1430